FAB — Fusion Antibodies Share News
0.000.00%
- £17.50m
- £17.64m
- £1.97m
REG - Fusion Antibodies - Grant of patent in Japan
AnnouncementREG - Fusion Antibodies - Year-end trading statement
AnnouncementREG - Fusion Antibodies - Antibody IP transfer agreement
AnnouncementREG - Fusion Antibodies - Director/PDMR Shareholding
AnnouncementREG - Fusion Antibodies - Holding(s) in Company
AnnouncementREG - Fusion Antibodies - Holding(s) in Company
AnnouncementREG - Fusion Antibodies - Total Voting Rights
AnnouncementREG - AIM - AIM Notice - 30/01/2026
AnnouncementREG - Fusion Antibodies - Issue of Director Shares
AnnouncementREG - Fusion Antibodies - Placing and Subscription to raise approx £1.4m
AnnouncementREG - Fusion Antibodies - Update on negotiations with NCI regarding OptiMAL
AnnouncementREG - Fusion Antibodies - Launch of OptiMAL platform
AnnouncementRCS - Fusion Antibodies - Mammalian Display video
AnnouncementREG - Fusion Antibodies - Holding(s) in Company
AnnouncementREG - Fusion Antibodies - Half-year Financial Report
AnnouncementREG - Fusion Antibodies - Notice of Results
AnnouncementRCS - Fusion Antibodies - OptiMAL Library video
AnnouncementREG - Fusion Antibodies - OptiMAL® R&D Update
AnnouncementREG - Fusion Antibodies - Holding(s) in Company
Announcement